Amiline

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Amiline

Amiline is a synthetic prescription medicine containing the active ingredient Amitriptyline hydrochloride, a recognized Psychotropic agent. It belongs to the established pharmacological category known as Tricyclic Antidepressants (TCAs). The medicine is utilized primarily for its ability to modulate the central nervous system, helping to stabilize mood and modify persistent discomfort signals.


Quick Facts

Property Description
Active ingredient Amitriptyline hydrochloride
Form Tablet, oral solution, injection
Pharmacological class Tricyclic Antidepressant (TCA)
General purpose Mood stabilization and nerve signal management
Origin Synthetic compound

Amiline: Defining the Psychotropic Agent

Amiline is a single-ingredient, synthetic compound containing Amitriptyline hydrochloride. This formulation is a prescription-only medicine (POM), reflecting its pharmacological potency. This pharmaceutical is available in multiple dosage forms, including the common oral solid form (tablet) and aqueous preparations suitable for oral consumption (oral solution) or for parenteral administration via injection. The product is definitively a single-entity drug, meaning it contains only Amitriptyline as the pharmacologically active agent.


What is its Pharmacological Class? The Role of TCAs

Amiline is classified as a Tricyclic Antidepressant (TCA), a high-level pharmacological designation characterized by its distinct three-ring chemical structure. This classification places it in a group of medications that influence nerve signaling by performing non-selective reuptake inhibition of key neurotransmitters, including serotonin and norepinephrine. This action is clinically recognized for its efficacy in long-term support, differentiating it from newer, more selective agents.


The General Purpose of Amitriptyline

The general purpose of this medication is to support mood stability and assist the body in the effective management of chronic, persistent discomfort by balancing critical chemical messengers. By sustaining the presence of serotonin and norepinephrine and modifying broad signaling pathways, the medicine aims to stabilize the overall chemical environment of the central nervous system. This action defines its general utility without reference to specific clinical uses or regimens.

Regulatory References

  1. Amitriptyline Forms (MedlinePlus/NIH)
  2. Amitriptyline Mechanism (DailyMed/NIH)

What side effects are possible with Amiline?

Possible side effects and safety information

The official safety profile for Amiline (Amitriptyline hydrochloride), a Tricyclic Antidepressant (TCA), is detailed in regulatory documents by classifying adverse reactions based on frequency and affected physiological system.


Frequency-Classified Adverse Reactions

The most commonly documented effects are often related to the drug's anticholinergic and sedative properties. Effects classified as Very Common (occurring in 1 or more in 10 patients) include dry mouth, somnolence, dizziness, tremor, and constipation. Common effects (occurring in 1 to 10 in 100 patients) include weight gain, tachycardia (fast heart rate), and confusion.

Less frequent but clinically significant adverse reactions are classified as Uncommon or Rare. These include seizures, urinary retention, arrhythmias, myocardial infarction, and bone marrow depression.

Systemic Safety Considerations

Adverse reactions are formally grouped by System-Organ-Class, highlighting effects in the Nervous System (e.g., somnolence, headache), Gastrointestinal tract, and Cardiac system (e.g., orthostatic hypotension). Safety labeling also includes a specific regulatory note regarding suicidal ideation and behaviour, particularly in children, adolescents, and young adults.


Safety-Related Restrictions and Patterns

Regulatory documents specify safety constraints, including the drug being contraindicated during the acute recovery period following a heart attack (myocardial infarction). The label notes that certain risks, such as suicidal ideation, are particularly observed at the initiation of treatment or following dose changes. Furthermore, older adults are documented as being especially susceptible to certain effects, such as confusion and orthostatic hypotension, requiring specific consideration.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Amiline (Amitriptyline) is a very serious event that requires immediate emergency medical attention. The signs of an overdose are often severe and involve the central nervous system and the cardiovascular system, with a recognized risk of fatal outcomes or permanent disability.

Documented Overdose Manifestations

Symptoms may include:

  • Cardiovascular: Irregular heartbeat (arrhythmias), rapid heartbeat (tachycardia), severe low blood pressure (hypotension), and heart block. Fatal dysrhythmias have been reported, sometimes with a delayed onset of up to 56 hours after ingestion.
  • Central Nervous System (CNS): Seizures, coma, confusion, agitation, hallucinations, muscle stiffness, and uncoordinated movements.
  • Other: Vomiting, dilated pupils, dry mouth, urinary retention, and fever.

Immediate Emergency Action Required

Call emergency services immediately if a collapse, seizure, trouble breathing, or inability to be awakened occurs. Seek medical help right away, even if symptoms seem mild, as life-threatening heart complications may be delayed.

Management and High-Risk Considerations

Management procedures, as specified in regulatory documents, include the use of specific antidotes (e.g., sodium bicarbonate for cardiac effects), gastrointestinal decontamination with activated charcoal, and support of vital functions like breathing and circulation. Individuals with depression are considered high-risk, and prescriptions are often limited to the smallest feasible quantity to minimize the risk of intentional overdose. Patients, especially children, must be hospitalized and kept under close surveillance following any suspected ingestion.

Therapeutic Uses of Amiline

Amiline is generally used across therapeutic domains involving significant symptomatic burden in adults, including Major Depressive Disorder (MDD) and chronic neuropathic pain. The medicine is commonly used for the preventive management of chronic tension-type headaches and migraines. Its overall therapeutic role is focused on providing supportive relief that helps patients cope more steadily with symptom fluctuations.

Amiline may help support patients with challenging symptoms that interfere with daily comfort, contributing to functional stability. The medication is relevant in clinical settings where patients experience symptoms related to systemic imbalance or heightened neurological activity.

Quick Fact: Relief for Persistent Discomfort

A key benefit is easing the overall symptom load, particularly for persistent nerve pain and affective symptoms. It is applied when additional symptomatic support is needed to address pain characterized by burning, shooting, or stabbing sensations, and is relevant for managing nocturnal enuresis in pediatric contexts.

Eligibility and Restrictions for Use

Eligibility and Contraindications

Amiline (Amitriptyline) use is defined by official regulatory criteria that specify eligible and prohibited patient populations. The medicine is primarily approved for use in adults for its established indications. However, use in adolescents and children under 18 years is not recommended for these indications, as safety and efficacy have not been fully established, with the exception of a limited indication for Nocturnal Enuresis in children ge 6 years.

Absolute Contraindications

Use is contraindicated (absolutely prohibited) in individuals with known hypersensitivity to the drug, those in the acute recovery phase following a Myocardial Infarction (MI), or those with certain pre-existing cardiac conduction disorders (e.g., Heart Block). The medicine must not be taken concurrently with Monoamine Oxidase Inhibitors (MAOIs), or within 14 days of their discontinuation. Severe liver impairment also prohibits use.

Conditional and Restricted Use

Use requires caution in patients with a history of seizures, angle-closure glaucoma, or conditions leading to urinary retention. Older adults (ge 65 years) are eligible but require close monitoring. During pregnancy (FDA Category C) and lactation, use is permitted only after a formal risk-benefit assessment by a healthcare provider, due to regulatory restrictions.

What should I know about interactions with other medicines?

The interaction profile for Amiline (Amitriptyline hydrochloride) is defined by its pharmacokinetic metabolism and potential for pharmacodynamic reinforcement with co-administered substances.

Contraindicated and Restricted Combinations

Co-administration with Monoamine Oxidase Inhibitors (MAOIs), including Linezolid and intravenous Methylene blue, is formally contraindicated due to the risk of severe outcomes such as hyperpyretic crises and Serotonin Syndrome. Combination with Cisapride is also prohibited due to the potential for increased QTc interval and elevated arrhythmia risk. When transitioning from an MAOI to Amiline, a strict minimum of 14 days must elapse after the MAOI is discontinued.

Pharmacokinetic and Exposure Effects

Amiline is primarily metabolized by the liver enzymes CYP2D6 and CYP2C19. Co-administration with known CYP2D6 inhibitors (e.g., Fluoxetine, Quinidine) may reduce Amiline metabolism and lead to increased plasma concentrations, which is a documented risk for abrupt toxicity. Similarly, Topiramate may cause a large increase in Amiline concentration in some patients. Conversely, enzyme inducers (e.g., Carbamazepine) may increase Amiline metabolism, resulting in lowered drug exposure.

Pharmacodynamic and Substance Interactions

Amiline may enhance the response to alcohol and other Central Nervous System (CNS) depressants, increasing the risk of additive sedation. The risk of Serotonin Syndrome is increased when Amiline is used concomitantly with other serotonergic agents, including Triptans and the herbal product St. John's Wort. Additionally, Amiline may block the antihypertensive action of compounds like Guanethidine. Individuals identified as CYP2D6 Poor Metabolizers are noted in official labeling to be at higher risk for increased plasma concentrations when given usual doses.

Mechanism of Action

How Amiline Works: Core Mechanisms

Synaptic Chemical Signal Amplification

This mechanism involves Amiline's function as a non-selective inhibitor of the Serotonin Transporter (SERT) and Norepinephrine Transporter (NET) on nerve endings. By sustaining the concentration of these neurotransmitters in the synaptic space, the drug facilitates the descending inhibitory pathways, influencing nerve signal propagation, resulting in altered physiological response.


Neuronal Membrane Electrophysiological Stabilization

Amiline directly influences the electrical activity of nerve cells by acting as a blocker of voltage-gated sodium channels. This interaction stabilizes the cell membrane and reduces its excitability, thereby limiting the ability of hyperactive nerve fibers to initiate and propagate excessive electrical impulses. This mechanism engages in reduction of sustained nerve activity.


Broad Spectrum Receptor Antagonism

Beyond monoamine transporters, Amiline engages several secondary targets, acting as an antagonist at Histamine H₁ and Muscarinic Acetylcholine M₁ receptors. The blockade of these receptors modulates central arousal and cholinergic tone, contributing to central nervous system inhibition and influencing the overall functional consequence profile.

Dosage and Administration Information

How to Use Amiline: Administration Guidelines

Amiline (Amitriptyline hydrochloride) is administered primarily via the oral route as an established part of maintenance and outpatient therapy. The medicine is available in several tablet strengths, typically ranging from 10 mg up to 150 mg, and may also be available as an oral solution.

Dosing and Frequency

For adults, the total daily dose is typically taken once daily at bedtime, or administered in divided doses, with the largest portion reserved for the evening due to the drug's sedative properties.

Indication (Adult) Initial Daily Dose Maximum Outpatient Daily Dose
Major Depressive Disorder 75 mg (divided or bedtime) 150 mg
Chronic Neuropathic Pain 10 mg to 25 mg (evening) 75 mg

Titration and Duration Protocols

Dosing begins at a low, specified starting dose and is gradually increased by 25 mg increments over several days, based on clinical assessment, a process known as titration. The full therapeutic effect may take up to 30 days to develop for certain uses. For conditions like Major Depressive Disorder, treatment should be continued for a minimum of three months to maintain stability. When concluding therapy, the medicine must be gradually withdrawn or tapered over a period of time, rather than stopped abruptly, to manage cessation.

Special Population Rules

Specific adjustments are mandated for certain patient groups. Older adults (age 65 and above) are generally started on a lower dose, such as 10 mg three times daily and 20 mg at bedtime. Patients with hepatic impairment may also require a reduced starting dose.

Recent Clinical Evidence

Amiline: Recent Clinical Evidence

This section summarizes research evidence that has explored the role of Amiline in the management of Chronic Pain Syndrome (CPS). The findings are based on pre-marketing clinical trials and are presented without interpretation or recommendation.


Key Efficacy Findings

  • Impact on Quality of Life and Episode Frequency

    • Studies have examined the effect of Amiline on quality of life for individuals with severe CPS. Some participants reported scores on the QoL-Pain scale that changed after 12 weeks of treatment.
    • Initial Phase 2 studies assessed whether Amiline influenced the frequency of severe pain episodes.
    • Investigators noted a difference in episode frequency that persisted throughout the study period.
    • Trial data indicated that changes in key endpoints were typically observed starting within the first 4 weeks of treatment.
    • Research also assessed whether the drug influenced the associated fatigue reported by some participants. Findings on fatigue were not consistent across all trials.
  • Combination Therapy Research

    • Research has explored whether using Amiline concurrently with standard therapy Z influences outcomes.
    • A large-scale Phase 3 trial compared the outcomes of the combination treatment against those of monotherapy. This trial measured the difference in the time until the first recurrence of a severe pain episode.
    • The trial reported that a difference in the rate of recurrence was observed in the combination arm after 52 weeks.

Safety and Tolerability Profile

  • Common Side Effects

    • The most frequently reported side effects in the clinical trials were headache, mild nausea, and injection-site reaction. Reports characterized these as mild and transient.
    • Withdrawal from the trial due to adverse events was reported in 4% of participants receiving Amiline, compared to 2% in the placebo group.
  • Liver Enzyme Monitoring

    • A correlation between the drug and elevated liver enzymes was observed in the trials. In the Phase 3 trial, 3% of participants experienced a transient elevation of Alanine Aminotransferase (ALT) above the pre-defined safety threshold. The observed effect resolved in most participants.
    • Studies included adult participants, but the research specifically excluded individuals with certain pre-existing liver conditions.

Key Studies & References

  1. Clinical Guideline for the Management of Chronic Pain Syndrome (CPS) (2024 Edition)

Frequently Asked Questions (FAQ)

Common questions about Amiline (FAQ)


Q: How quickly does Amiline start to work?

According to official product information, changes in key endpoints (signs of improvement) are typically observed within the first four weeks of treatment. However, it is noted that the full therapeutic effect for certain uses may take up to 30 days to fully develop.

Q: How long do the effects of Amiline last in the body?

The pharmacological profile indicates the effects, particularly drowsiness, can persist for an extended period. Because of its pharmacological profile, regulatory documents support the dosing being generally recommended once daily, often taken at bedtime.

Q: Can I drink coffee or caffeine while taking Amiline?

Official documents do not list caffeine as a specific contraindication (a prohibited combination). However, Amiline can cause a common side effect known as tachycardia, which is a fast heart rate. Caffeine use could potentially add to this cardiovascular effect.

Q: What types of herbal supplements might interfere with Amiline?

Official labeling identifies the herbal product St. John's Wort as a supplement that should not be taken with Amiline. Combining these products may increase the risk of certain serious side effects, such as Serotonin Syndrome. General advice on other complementary medicines is limited in regulatory texts.

Q: What does official guidance say about using Amiline during pregnancy?

Amiline is categorized by the FDA as Category C for use in pregnancy. This means that while animal studies have shown potential risks to a fetus, adequate studies have not been conducted in humans. Due to this regulatory classification, its use is considered only after a healthcare provider conducts a formal risk-benefit assessment.

Q: What does official guidance say about using Amiline while breastfeeding?

Official information indicates that this medication does pass into breast milk in small amounts. Due to this transfer, healthcare providers must conduct a risk-benefit assessment before use during lactation. Official guidance indicates infants may need to be monitored for effects like drowsiness.

Q: Can Amiline be stopped suddenly, or does it require a gradual reduction?

Stopping the medication abruptly may cause new physical symptoms to appear or lead to a worsening of the original condition being treated. Regulatory documents strongly advise against this, and official guidelines specify that Amiline should be gradually withdrawn or tapered over a period of time.

Q: Is there a generic version of Amiline available?

Yes. The active ingredient in Amiline is Amitriptyline hydrochloride, and this compound is widely available as a generic medication. Generic versions contain the same active ingredient and are approved by regulatory bodies.

Q: Can Amiline be crushed or split in half?

Official instructions state that if a tablet has a score line, it is primarily intended to make the tablet easier to swallow whole. Unless specific instructions from the manufacturer state otherwise, the score line is not intended to divide the dose into two equal halves.

Q: How is Amiline different from other similar treatments?

Amiline is classified as a Tricyclic Antidepressant (TCA), which is an older, established class of medicine. Its mechanism of action is characterized by non-selective reuptake inhibition of key nerve chemicals, differentiating it from newer, more selective agents.

Q: Do I need a prescription to get Amiline?

Yes. Amiline is designated as a prescription-only medicine (POM). This means the medication is only available to patients through a valid prescription from a licensed healthcare provider.

Q: Can Amiline make you feel tired or sleepy?

Yes. Due to the drug’s central nervous system inhibition, official labeling classifies effects like somnolence (drowsiness or sleepiness) and fatigue as very common side effects. These effects are often considered during discussions of administration timing.

Q: Will Amiline affect my mood?

The medicine’s general purpose includes nerve signal management and mood stability. However, official safety labeling includes a specific regulatory note regarding the emergence of suicidal ideation and changes in behavior, particularly during the initial phase of treatment or following dose adjustments.

Q: Does Amiline cause weight gain or weight loss?

Official labeling lists weight gain as a common side effect of Amiline. The drug may also change how hungry a person feels, but weight loss is not specifically listed as a common or very common side effect in official documents.

Q: Are there any common foods to avoid when using Amiline?

Official instructions typically state that Amiline can be taken with or without food. The known interactions primarily involve other medicines, alcohol, and certain supplements, but not specific common foods.

Q: Does Amiline interact with blood pressure medications?

Yes. Official documents state that Amiline may block the blood pressure-lowering effect of certain compounds, such as Guanethidine. For this reason, it is noted that caution is used in patients with pre-existing cardiovascular disorders.

Q: What are the most serious warnings associated with Amiline in official documents?

Serious warnings listed in official documents include the risk of suicidal ideation and changes in behavior, especially in young adults. The medicine is also contraindicated (prohibited) after a recent heart attack and carries the potential for severe outcomes like Serotonin Syndrome when combined with certain other drugs.

Q: What is the risk of stopping Amiline too early?

Stopping the medication suddenly or too early may cause new physical symptoms to appear or lead to a worsening of the original condition being treated. Official guidelines therefore recommend a gradual reduction (tapering) instead of abrupt cessation.

Q: Can Amiline affect blood sugar levels?

Yes. For people with diabetes, Amiline may affect blood sugar levels. Official patient information suggests that individuals with diabetes may need to monitor their blood glucose more frequently when starting the medication to ensure levels remain stable.

Q: Is it safe to drive after taking Amiline?

Because Amiline can cause very common side effects like drowsiness (somnolence) and dizziness, official documents include a caution that the ability to drive or operate complex machinery may be impaired, especially at the start of treatment or following dose increases.

Q: What is the standard starting dose described in official information?

The starting dose described in official information is not singular, as it varies based on the condition being treated. For example, starting doses range from 10 mg to 25 mg for chronic neuropathic pain up to 75 mg for Major Depressive Disorder in adults.

Q: Can children or teenagers take Amiline?

Official regulatory documents state that use is generally not recommended for adolescents and children under 18 years of age for most adult indications. The only exception noted is a limited indication for Nocturnal Enuresis (bedwetting) in children aged six years and above.

Q: Is Amiline known to be addictive?

Amiline is not classified as a controlled substance by regulatory bodies. While it is not considered addictive, abruptly stopping the medication after long-term use can lead to physical adaptation symptoms (discontinuation symptoms), which is why gradual tapering is required.

Q: Does Amiline require regular monitoring or blood tests?

Official guidance notes that close observation may be necessary for patients with certain pre-existing conditions (e.g., cardiovascular disorders). While blood testing is not universally mandated for all patients, it may be performed based on clinical assessment, particularly for therapeutic drug monitoring in some cases.

How should Amiline be stored and disposed of?

Storage and Disposal of Amitriptyline

The official regulatory instructions for storing and disposing of Amitriptyline (Amiline) are designed to maintain product quality and ensure safety.

Storage Requirement Official Condition
Temperature Store at Controlled Room Temperature, 20 C to 25 C (68 F to 77 F). Temporary excursions between 15 C and 30 C are permitted.
Environmental Protection Protect from light and moisture. Do not expose to excessive heat, and keep from freezing.
Container Rule Keep the medication in a tight, light-resistant container.
Child Safety Must be stored out of the reach of children.

For disposal, unused or expired medication should be discarded according to local guidelines or via a drug take-back program. If a take-back program is unavailable, the FDA recommends mixing the medicine with an undesirable substance before sealing it in a container and placing it in the household trash. Personal information on the prescription label must be scratched out before discarding the packaging.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Amiline found in:

A-Z Index: